Topiramate
Product Images NDC 83008-012

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 83008-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0ed6c856 4d95 4aeb B925 15346555a2ab 565 2)

FDA Label Image

Image Description (25mg)

Image Description (25mg)
Packaged and Distributed by LoAlely Care Products, this is a prescription medication called Topiramate Tablets, USP 25 mg. It is manufactured by UNICHEM LABORATORIES LTD. and distributed by UNICHEM PHARMACEUTICALS (USA), INC. The medication is available in a bottle containing 60 tablets. The product should be stored at a temperature between 68 to 77 degrees F. The full prescribing information is available. The contact number for any queries is 1-800-337-8603.*
FDA Label Image

Image Description (50mg)

FDA Label Image

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 01)

FDA Label Image

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 02)

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 02)
Cumulative Rates for Time to First Seizure: This data represents the cumulative rates of time it takes for the first seizure to occur. The rates are shown on a scale from 0 to 050, with a decrease in seizure rate as the numbers decrease. The specific medication being tested is topiramate, with two different dosages being compared: 50 mg/day and 400 mg/day. The results indicate that the higher dosage of 400 mg/day led to a significantly lower seizure rate compared to the lower dosage of 50 mg/day, as indicated by the p-value of 00002. The graph shows the time in days on the x-axis, ranging from 0 to 400, and the cumulative rates on the y-axis. As time progresses, the seizure rate decreases for both dosages, but the decrease is more pronounced for the higher dosage of topiramate.*
FDA Label Image

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.